117 related articles for article (PubMed ID: 9400936)
21. BRCA2 mutations in primary breast and ovarian cancers.
Lancaster JM; Wooster R; Mangion J; Phelan CM; Cochran C; Gumbs C; Seal S; Barfoot R; Collins N; Bignell G; Patel S; Hamoudi R; Larsson C; Wiseman RW; Berchuck A; Iglehart JD; Marks JR; Ashworth A; Stratton MR; Futreal PA
Nat Genet; 1996 Jun; 13(2):238-40. PubMed ID: 8640235
[TBL] [Abstract][Full Text] [Related]
22. High incidence of loss of heterozygosity at chromosome 17p13 in breast tumours from BRCA2 mutation carriers.
Eiriksdottir G; Barkardottir RB; Agnarsson BA; Johannesdottir G; Olafsdottir K; Egilsson V; Ingvarsson S
Oncogene; 1998 Jan; 16(1):21-6. PubMed ID: 9467939
[TBL] [Abstract][Full Text] [Related]
23. Double heterozygosity for mutations in the BRCA1 and BRCA2 genes in a breast cancer patient.
Tsongalis GJ; Linfert DR; Johnson RC; Ackroyd R; Berman MM; Ricci A
Arch Pathol Lab Med; 1998 Jun; 122(6):548-50. PubMed ID: 9625424
[TBL] [Abstract][Full Text] [Related]
24. Loss of heterozygosity in the RAD51 and BRCA2 regions in breast cancer.
Nowacka-Zawisza M; Bryś M; Romanowicz-Makowska H; Kulig A; Krajewska WM
Cancer Detect Prev; 2008; 32(2):144-8. PubMed ID: 18632222
[TBL] [Abstract][Full Text] [Related]
25. Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas.
Freihoff D; Kempe A; Beste B; Wappenschmidt B; Kreyer E; Hayashi Y; Meindl A; Krebs D; Wiestler OD; von Deimling A; Schmutzler RK
Br J Cancer; 1999 Feb; 79(5-6):754-8. PubMed ID: 10070865
[TBL] [Abstract][Full Text] [Related]
26. Allelic imbalance on chromosomes 13 and 17 and mutation analysis of BRCA1 and BRCA2 genes in monozygotic twins concordant for breast cancer.
Försti A; Luo L; Vorechovsky I; Söderberg M; Lichtenstein P; Hemminki K
Carcinogenesis; 2001 Jan; 22(1):27-33. PubMed ID: 11159737
[TBL] [Abstract][Full Text] [Related]
27. Survival in hereditary breast cancer associated with germline mutations of BRCA2.
Verhoog LC; Brekelmans CT; Seynaeve C; Dahmen G; van Geel AN; Bartels CC; Tilanus-Linthorst MM; Wagner A; Devilee P; Halley DJ; van den Ouweland AM; Meijers-Heijboer EJ; Klijn JG
J Clin Oncol; 1999 Nov; 17(11):3396-402. PubMed ID: 10550133
[TBL] [Abstract][Full Text] [Related]
28. Loss of BRCA2 correlates with reduced long-term survival of sporadic breast cancer patients.
Hampl JA; Hampl M; Reiss G; Koch R; Saeger HD; Schackert HK
Anticancer Res; 2004; 24(1):281-90. PubMed ID: 15015609
[TBL] [Abstract][Full Text] [Related]
29. BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers.
Maxwell KN; Wubbenhorst B; Wenz BM; De Sloover D; Pluta J; Emery L; Barrett A; Kraya AA; Anastopoulos IN; Yu S; Jiang Y; Chen H; Zhang NR; Hackman N; D'Andrea K; Daber R; Morrissette JJD; Mitra N; Feldman M; Domchek SM; Nathanson KL
Nat Commun; 2017 Aug; 8(1):319. PubMed ID: 28831036
[TBL] [Abstract][Full Text] [Related]
30. Lymph node metastasis is associated with allelic loss on chromosome 13q12-13 in esophageal squamous cell carcinoma.
Harada H; Tanaka H; Shimada Y; Shinoda M; Imamura M; Ishizaki K
Cancer Res; 1999 Aug; 59(15):3724-9. PubMed ID: 10446988
[TBL] [Abstract][Full Text] [Related]
31. BRCA2 protein expression in sporadic breast carcinoma with or without allelic loss of BRCA2.
Bernard-Gallon D; Peffault De Latour M; Rio P; Favy D; Hizel C; Vissac C; Bignon YJ
Int J Cancer; 2000 May; 86(4):453-6. PubMed ID: 10797254
[TBL] [Abstract][Full Text] [Related]
32. Molecular prognostic markers in breast cancer.
Dahiya R; Deng G
Breast Cancer Res Treat; 1998; 52(1-3):185-200. PubMed ID: 10066082
[TBL] [Abstract][Full Text] [Related]
33. High incidence of loss of heterozygosity in breast tumors from carriers of the BRCA2 999del5 mutation.
Ingvarsson S; Geirsdottir EK; Johannesdottir G; Sigbjörnsdóttir BI; Eiriksdottir G; Ragnarsson G; Agnarsson BA; Gudmundsson J; Jonasson JG; Sigurdsson A; Egilsson V; Barkardottir RB
Cancer Res; 1998 Oct; 58(19):4421-5. PubMed ID: 9766673
[TBL] [Abstract][Full Text] [Related]
34. Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer.
Steinmann D; Bremer M; Rades D; Skawran B; Siebrands C; Karstens JH; Dörk T
Br J Cancer; 2001 Sep; 85(6):850-8. PubMed ID: 11556836
[TBL] [Abstract][Full Text] [Related]
35. Loss of heterozygosity on chromosome 13q: suggestion of a candidate tumor suppressor gene in sporadic breast cancer.
Tong D; Schuster E; Czerwenka K; Leodolter S; Zeillinger R
Breast Cancer Res Treat; 2004 Jan; 83(2):143-8. PubMed ID: 14997045
[TBL] [Abstract][Full Text] [Related]
36. Chromosome imbalance at the 3p14 region in human breast tumours: high frequency in patients with inherited predisposition due to BRCA2.
Bergthorsson JT; Johannsdottir J; Jonasdottir A; Eiriksdottir G; Egilsson V; Ingvarsson S; Barkardottir RB; Arason A
Eur J Cancer; 1998 Jan; 34(1):142-7. PubMed ID: 9624249
[TBL] [Abstract][Full Text] [Related]
37. Germline BRCA2 mutations in men with breast cancer.
Mavraki E; Gray IC; Bishop DT; Spurr NK
Br J Cancer; 1997; 76(11):1428-31. PubMed ID: 9400938
[TBL] [Abstract][Full Text] [Related]
38. Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13.
Collins N; McManus R; Wooster R; Mangion J; Seal S; Lakhani SR; Ormiston W; Daly PA; Ford D; Easton DF
Oncogene; 1995 Apr; 10(8):1673-5. PubMed ID: 7731724
[TBL] [Abstract][Full Text] [Related]
39. Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping.
Oldenburg RA; Kroeze-Jansema K; Meijers-Heijboer H; van Asperen CJ; Hoogerbrugge N; van Leeuwen I; Vasen HF; Cleton-Jansen AM; Kraan J; Houwing-Duistermaat JJ; Morreau H; Cornelisse CJ; Devilee P
Clin Cancer Res; 2006 Mar; 12(6):1693-700. PubMed ID: 16551851
[TBL] [Abstract][Full Text] [Related]
40. Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13.
Gudmundsson J; Johannesdottir G; Bergthorsson JT; Arason A; Ingvarsson S; Egilsson V; Barkardottir RB
Cancer Res; 1995 Nov; 55(21):4830-2. PubMed ID: 7585515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
